Background：Kangfuxin Liquid is extracted from America periplaneta, which is effective for treating gastrointestinal
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intestinal barrier dysfunction and worse yet-failure often occurs (Pan et al., 2016) . When elderly patients have intestinal barrier dysfunction, it can be argued that this condition had been aggravated or alternatively that the prognosis was poor (Geboes et al., 2002) . Therefore, it has practical significance to protect elderly patients who have intestinal barrier function with mechanical ventilation in the early stage.
At present, the topic of elderly patients in critical stages with intestinal barrier dysfunction has been receiving more attention and likewise its prevention. Many traditional medicines for treating intestinal barrier dysfunction have achieved satisfactory results (Qiu et al., 2011; Fang et al., 2006) . Kangfuxin Liquid is extracted from America periplaneta, which belongs to the insect medicines with effectiveness on gastrointestinal ulcer and repairs gastrointestinal mucosal tissue (Wang et al., 2013; Zhang et al., 2012) . Kangfuxin Liquid is used to improve the intestinal barrier dysfunction in elderly patients, and explore the effect on restraining the concentration of D-lactate.
Materials and Methods
Trial design: This study used a prospective randomized controlled trial and the sample size was first established and evaluated. The subject patients were assigned into "treatment" and "control" groups using a random number table with thirty-one patients comprising each group. The detection and record of evaluation index was performed by two independent investigators. Both investigators were unaware of the treatment allocation.
Study population:
During the period January 2010 to December 2012, a total of 62 elderly patients with mechanical ventilation in ICU were selected from our hospitals, 35 male, 27 female, ranging in age from 61 to 75 years. Their primary diseases were severe pneumonia, pulmonary embolism, chest trauma, cerebro-vascular disease, brain injury, poisoning, and other illnesses.
Ethics: This research protocol was approved by our hospital's committee in accordance with the ethical standards set out in the 1964 Declaration of Helsinki and its later amendments. Before commencing this study all patients or their families were informed, consent given for treatment, and an agreement was signed. .
Inclusion criteria:
The patients with mechanical ventilation were older than 60 years of age; Their APACHE II score was greater than or equal to 12 points; and their records indicated they never had peptic ulcers or any other gastrointestinal disease.
Exclusion criteria:
Patients not chosen were those who had the following issues: Patients who had used anti cholinergic or gastrointestinal motility medicines within the previous week, those suffering from primary disease in their digestive system, others with severe intra-abdominal infections, those infected with human immunodeficiency virus, and those with Parkinson's disease, hyperthyroidism and epilepsy.
Intervention: All patients were provided comprehensive treatment, including the treatment of their initial disease, blood transfusion, oxygen, analgesic sedation, maintenance of water electrolyte balance and any other considerations.
There were no statistically differences between these two sample groups. "Treatment" patients additionally received Kangfuxin Liquid (Hunan Kelun Pharmaceutical Co., Ltd. Chian), Kangfuxin Liquid via a naso-gastric tube, 10 ml each time, 3 times each day, for 7 days.
Evaluation index:
At baseline and at 3 and 7 day intervals following treatment, all patients were respectively extracted venous blood for testing the concentration of D-lactate. At the same time, intra-abdominal pressure (IAP) and bowel sounds were recorded. Monitoring of intra-abdominal pressure was conducted by bladder manometry . The duration of mechanical ventilation, the time of stay in ICU and the mortality rate during 28 days were recorded. Any adverse drug reactions in all enrolled patients during this trial were recorded.
Statistical analysis:
The analysis was determined applying SPSS17.0 software (SPSS software Inc., Chicago, IL, USA). Continuous data was expressed as mean ± standard deviation; the differences between groups were tested with the Student t-test. Percentage and non-normally distributed data were compared for statistical significance using Chi square-test or the Mann-Whitney U-test. The significance level was established at p <0.05 (two-sided).
Results

Patient characteristics:
No patients were excluded and all 62 subjects entered the statistical analysis. There were no adverse drug reactions in any of these patients during this trial. There were no significant differences in the terms of gender, age, weight, primary disease, APACHE II score between the two groups (P>0.05). The mortality rates during 28 days within both groups were 38.71% and 35.48%, the treatment group was lower than the control group, but the difference was not statistically significant (P>0.05). The duration of mechanical ventilation and the time of stay in ICU in the treatment group were less than those in the control group (P<0.05). Refer to Table 1 . Change of bowel sounds: At baseline, there was no statistical difference of the bowel sounds between the two groups (P>0.05). At 3 and 7-days following treatment, the bowel sounds in treatment group were higher than those in control group, and these differences were statistically significant (P<0.05). Refer to Gastrointestinal tract is the portal for effective control of MODS, and effective prevention. Treatment of intestinal barrier dysfunction is the key to preventing the occurrence of MODS, which can reduce the mortality rate in critical patients (Rings, 2004) . Therefore, it is important that effective intervention on intestinal barrier function in elderly patients having mechanical ventilation in its early stage be applied for controlling the patients' condition.
The increased permeability of intestinal mucosa is an important manifestation of intestinal mucosal barrier dysfunction (Bjarnason et al., 1995) . When the hypoperfusion injury of intestinal mucosa occurs, the uppermost . In this study, the treatment group given Kangfuxin Liquid, saw D-lactate decreasing, intra-abdominal pressure falling and accompanying bowel sounds increasing at 3 and 7-days following treatment. The changes using these indicators in the "treatment" group were superior than those in the "control" group.
These results confirm Kangfuxin Liquid as a protective medicine for intestinal mucosa promoting intestinal peristalsis and enhancing the intestinal barrier function.
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